Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.
Are you up for a little challenge? Test your diagnostic acumen with these 5 questions.
How best to determine clinically inactive disease: Wallace’s preliminary criteria versus the clinical juvenile arthritis disease activity score.
Actemra can be given alone or in combination with methotrexate in patients with polyarticular juvenile idiopathic arthritis.
Role of Epstein-Barr virus in autoimmune diseases, impact of consensus treatment plans, and the search for biomarkers for juvenile arthritis.
An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis
Monotherapy can lead to clinically inactive disease—but only in select patients.
The aim of this study: to determine which patients need biologic therapy after starting methotrexate.
The risk of pregnancy-related complications is further increased when juvenile arthritis persists into adulthood.
Canakinumab lowers CRP level and may significantly lower the incidence of recurrent cardiovascular events.